FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2815360664> ?p ?o ?g. }

• W2815360664 abstract "Infiltration into lymphatic vessels is a critical step in breast cancer metastasis. Lymphatics undergo changes that facilitate metastasis as a result of activation of the cells lining lymphatic vessels, lymphatic endothelial cells (LECs). Inhibition of activation by targeting VEGFR3 can reduce invasion toward lymphatics. To best benefit patients, this approach should be coupled with standard of care that slows tumor growth, such as chemotherapy. Little is known about how chemotherapies, like docetaxel, may influence lymphatics and conversely, how lymphatics can alter responses to therapy.A novel 3D in vitro co-culture model of the human breast tumor microenvironment was employed to examine the contribution of LECs to tumor invasion and viability with docetaxel and anti-VEGFR3, using three cell lines, MDA-MB-231, HCC38, and HCC1806. In vivo, the 4T1 mouse model of breast carcinoma was used to examine the efficacy of combinatorial therapy with docetaxel and anti-VEGFR3 on lymph node metastasis and tumor growth. Lymphangiogenesis in these mice was analyzed by immunohistochemistry and flow cytometry. Luminex analysis was used to measure expression of lymphangiogenic cytokines.In vitro, tumor cell invasion significantly increased with docetaxel when LECs were present; this effect was attenuated by inhibition of VEGFR3. LECs reduced docetaxel-induced cell death independent of VEGFR3. In vivo, docetaxel significantly increased breast cancer metastasis to the lymph node. Docetaxel and anti-VEGFR3 combination therapy reduced lymph node and lung metastasis in 4T1 and synergized to reduce tumor growth. Docetaxel induced VEGFR3-dependent vessel enlargement, lymphangiogenesis, and expansion of the LEC population in the peritumoral microenvironment, but not tumor-free stroma. Docetaxel caused an upregulation in pro-lymphangiogenic factors including VEGFC and TNF-α in the tumor microenvironment in vivo.Here we present a counter-therapeutic effect of docetaxel chemotherapy that triggers cancer cells to elicit lymphangiogenesis. In turn, lymphatics reduce cancer response to docetaxel by altering the cytokine milieu in breast cancer. These changes lead to an increase in tumor cell invasion and survival under docetaxel treatment, ultimately reducing docetaxel efficacy. These docetaxel-induced effects can be mitigated by anti-VEGFR3 therapy, resulting in a synergism between these treatments that reduces tumor growth and metastasis." @default.
• W2815360664 created "2018-07-19" @default.
• W2815360664 creator A5009561892 @default.
• W2815360664 creator A5034755939 @default.
• W2815360664 creator A5049365455 @default.
• W2815360664 date "2018-07-06" @default.
• W2815360664 modified "2023-10-15" @default.
• W2815360664 title "Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression" @default.
• W2815360664 cites W1555009525 @default.
• W2815360664 cites W1570971207 @default.
• W2815360664 cites W167359183 @default.
• W2815360664 cites W1968028469 @default.
• W2815360664 cites W1982276721 @default.
• W2815360664 cites W1983129031 @default.
• W2815360664 cites W1985830305 @default.
• W2815360664 cites W1988965316 @default.
• W2815360664 cites W2001268727 @default.
• W2815360664 cites W2001868807 @default.
• W2815360664 cites W2002689409 @default.
• W2815360664 cites W2013317185 @default.
• W2815360664 cites W2014214300 @default.
• W2815360664 cites W2016054079 @default.
• W2815360664 cites W2021891258 @default.
• W2815360664 cites W2030083320 @default.
• W2815360664 cites W2040016252 @default.
• W2815360664 cites W2041259212 @default.
• W2815360664 cites W2041497771 @default.
• W2815360664 cites W2043249221 @default.
• W2815360664 cites W2048214675 @default.
• W2815360664 cites W2056598826 @default.
• W2815360664 cites W2059287676 @default.
• W2815360664 cites W2064935797 @default.
• W2815360664 cites W2067526965 @default.
• W2815360664 cites W2070743887 @default.
• W2815360664 cites W2071896339 @default.
• W2815360664 cites W2079395387 @default.
• W2815360664 cites W2081174442 @default.
• W2815360664 cites W2084290454 @default.
• W2815360664 cites W2087179076 @default.
• W2815360664 cites W2095619115 @default.
• W2815360664 cites W2097471654 @default.
• W2815360664 cites W2105681978 @default.
• W2815360664 cites W2109481082 @default.
• W2815360664 cites W2113215822 @default.
• W2815360664 cites W2114639059 @default.
• W2815360664 cites W2115852392 @default.
• W2815360664 cites W2117579165 @default.
• W2815360664 cites W2120159810 @default.
• W2815360664 cites W2126882378 @default.
• W2815360664 cites W2130247045 @default.
• W2815360664 cites W2131213654 @default.
• W2815360664 cites W2134539328 @default.
• W2815360664 cites W2136274729 @default.
• W2815360664 cites W2142414417 @default.
• W2815360664 cites W2144991724 @default.
• W2815360664 cites W2153100291 @default.
• W2815360664 cites W2155056678 @default.
• W2815360664 cites W2155579325 @default.
• W2815360664 cites W2156556190 @default.
• W2815360664 cites W2156808678 @default.
• W2815360664 cites W2161382947 @default.
• W2815360664 cites W2162442448 @default.
• W2815360664 cites W2164664027 @default.
• W2815360664 cites W2166216348 @default.
• W2815360664 cites W2171549753 @default.
• W2815360664 cites W2172298636 @default.
• W2815360664 cites W2176476431 @default.
• W2815360664 cites W2236309106 @default.
• W2815360664 cites W2237765743 @default.
• W2815360664 cites W2300411058 @default.
• W2815360664 cites W2345367149 @default.
• W2815360664 cites W2430768330 @default.
• W2815360664 cites W2535545320 @default.
• W2815360664 cites W2539367458 @default.
• W2815360664 cites W2600254598 @default.
• W2815360664 cites W2610682271 @default.
• W2815360664 cites W2623661612 @default.
• W2815360664 cites W2774754307 @default.
• W2815360664 cites W2967276830 @default.
• W2815360664 cites W337779885 @default.
• W2815360664 cites W560736474 @default.
• W2815360664 doi "https://doi.org/10.1186/s12885-018-4619-8" @default.
• W2815360664 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6034223" @default.
• W2815360664 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29976154" @default.
• W2815360664 hasPublicationYear "2018" @default.
• W2815360664 type Work @default.
• W2815360664 sameAs 2815360664 @default.
• W2815360664 citedByCount "42" @default.
• W2815360664 countsByYear W28153606642018 @default.
• W2815360664 countsByYear W28153606642019 @default.
• W2815360664 countsByYear W28153606642020 @default.
• W2815360664 countsByYear W28153606642021 @default.
• W2815360664 countsByYear W28153606642022 @default.
• W2815360664 countsByYear W28153606642023 @default.
• W2815360664 crossrefType "journal-article" @default.
• W2815360664 hasAuthorship W2815360664A5009561892 @default.
• W2815360664 hasAuthorship W2815360664A5034755939 @default.
• W2815360664 hasAuthorship W2815360664A5049365455 @default.
• W2815360664 hasBestOaLocation W28153606641 @default.
• W2815360664 hasConcept C121608353 @default.

• next